![Sailaja Puttagunta](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sailaja Puttagunta
Geen lopende functies
Vermogen: 311 $ op 31-03-2026
Profiel
Sailaja Puttagunta formerly worked at Durata Therapeutics, Inc., as Vice President-Development & Medical Affairs in 2014, Allergan UC, as Vice President-Medical Affairs from 2015 to 2016, Iterum Therapeutics Plc, as Vice President-Development from 2016 to 2018, BiomX Ltd., as Chief Medical Officer from 2018 to 2019, BiomX, Inc., as Chief Medical Officer from 2019 to 2021, and Iterum Therapeutics Plc, as Chief Medical Officer from 2021 to 2024.
Dr. Puttagunta received her graduate degree from New York University School of Medicine and undergraduate degree from Gandhi Medical College & Hospital.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-11-2025 | 10.369 ( 0,02% ) | 311 $ | 31-03-2026 |
Eerdere bekende functies van Sailaja Puttagunta
| Bedrijven | Functie | Einde |
|---|---|---|
| ITERUM THERAPEUTICS PLC | Hoofd Techniek/Wetenschap/O&O | 31-05-2024 |
| BIOMX INC. | Hoofd Techniek/Wetenschap/O&O | 13-12-2021 |
BiomX Ltd.
 BiomX Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer treatment | Hoofd Techniek/Wetenschap/O&O | 01-10-2019 |
| ITERUM THERAPEUTICS PLC | Corporate Officer/Principal | 01-12-2018 |
| ALLERGAN PLC | Hoofd Techniek/Wetenschap/O&O | 01-01-2016 |
Opleiding van Sailaja Puttagunta
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
34
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Durata Therapeutics, Inc.
 Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics for infectious diseases and acute illnesses | Health Technology |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gandhi Medical College & Hospital
 Gandhi Medical College & Hospital Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Iterum Therapeutics Plc
 Iterum Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem | Health Technology |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer treatment | Health Technology |
BiomX, Inc.
 BiomX, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company developing natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin | Health Technology |
